Apigenin: The Chamomile Flavone for Calm, Sleep, and NAD+ Longevity

Apigenin is a dietary flavone — a pale-yellow plant pigment in the flavonoid family — best known as the calming compound concentrated in chamomile flowers. It is also abundant in parsley (by far the richest food source), celery, and artichoke, and is found in smaller amounts in oregano, cilantro, and many fruits and vegetables. Long valued in herbal tradition for the soothing cup of chamomile tea at bedtime, apigenin has drawn fresh scientific interest for three distinct reasons: it binds a calming receptor in the brain, it slows the age-related drain on a key cellular fuel called NAD+, and it interferes with several growth signals that cancer cells rely on in laboratory studies.

This article separates what is genuinely known from what is still hopeful. Much of the apigenin literature is preclinical — done in test tubes and animals, not in people — and we say so plainly throughout. The strongest human data come not from isolated apigenin but from chamomile extract, a whole-plant preparation in which apigenin is one of many active molecules. We cover apigenin's structure and food sources, its calming and sleep effects through the GABA-A receptor, the longevity angle of CD38 inhibition and NAD+ preservation, its anti-cancer cell-signaling activity, its antioxidant and metabolic effects, and practical guidance on forms, dosing, bioavailability, and safety.

Table of Contents

  1. Structure and Food Sources
  2. Calm, Anxiety, and Sleep: The GABA-A Connection
  3. CD38 Inhibition and NAD+ Preservation: The Longevity Angle
  4. Anti-Cancer Cell Signaling (Preclinical)
  5. Antioxidant and Anti-Inflammatory Mechanism
  6. Metabolic Effects
  7. Forms, Dosing, and Bioavailability
  8. Safety and Interactions
  9. Research Papers
  10. Connections
  11. Featured Videos

Structure and Food Sources

Apigenin (chemically 4',5,7-trihydroxyflavone) belongs to the flavone subclass of flavonoids, a close cousin of luteolin (which carries one extra hydroxyl group). In plants it usually occurs bound to sugars as glycosides — for example apiin in parsley and celery — which the body must cleave before absorption. Apigenin is a relatively rare nutrient in that a handful of culinary herbs dominate the diet's supply.

Because so few foods are concentrated sources, typical Western dietary intake is modest — estimates in some populations land around 1–1.5 mg per day. That is one reason chamomile tea and supplements, rather than ordinary meals, are the usual way people seek a noticeable apigenin effect.

Calm, Anxiety, and Sleep: The GABA-A Connection

The classic explanation for chamomile's soothing reputation is that apigenin acts on the GABA-A receptor, the brain's main brake pedal. GABA is the chief calming neurotransmitter; benzodiazepine sedatives such as diazepam work by amplifying its signal at this same receptor. In laboratory binding studies, apigenin attaches at or near the benzodiazepine site and behaves as a mild positive modulator — nudging the calming response upward, but far more weakly and without the dependence profile of a prescription benzodiazepine. This is the most cited mechanism for why a warm cup of chamomile feels relaxing.

The honest caveat is that human evidence for isolated apigenin is limited. There are essentially no randomized trials of purified apigenin at supplement doses for anxiety or sleep. What human data exist come from chamomile extract, a multi-compound preparation. A randomized, placebo-controlled trial of standardized chamomile extract in people with mild-to-moderate generalized anxiety disorder found a modest but real reduction in anxiety, and a longer follow-up trial reported that continued use helped prevent relapse. A small placebo-controlled pilot in chronic insomnia hinted at gentle improvements in daytime functioning, and a systematic review and meta-analysis concluded that chamomile improves overall sleep quality and generalized anxiety, while the evidence for treating clinical insomnia specifically remained weaker. Observational data also link higher dietary apigenin intake with better self-reported sleep, but association is not proof.

The fair summary: the mechanism is plausible and the chamomile trials are encouraging, but no one has yet shown in a rigorous human trial that swallowing a typical apigenin capsule reliably improves sleep on its own. Treat it as a gentle, low-risk option rather than a proven sleep medicine.

CD38 Inhibition and NAD+ Preservation: The Longevity Angle

The newest reason apigenin appears in longevity discussions is its effect on a cellular fuel called NAD+ (nicotinamide adenine dinucleotide). NAD+ powers energy production in mitochondria, fuels DNA-repair enzymes (PARPs), and activates the sirtuins — a family of proteins involved in stress resistance and metabolic control. A central feature of aging is that NAD+ levels fall in many tissues, including the brain, as the years pass.

A major driver of that decline is an enzyme called CD38, whose activity rises with age and which consumes NAD+ as part of its normal job. The more CD38 activity, the faster the cell's NAD+ pool is spent. In a 2013 study, researchers identified apigenin as one of the more potent natural inhibitors of CD38: when obese mice were given apigenin, CD38 activity in the liver dropped and hepatic NAD+ rose — close to doubling in that tissue — alongside improvements in glucose handling and fat accumulation. The appeal of this route is that it raises NAD+ by slowing its breakdown, a different strategy from NAD+ precursor supplements such as NMN or NR, which supply more raw material.

Two cautions keep this firmly in the "promising hypothesis" column. First, this work is preclinical — the NAD+ and lifespan-relevant findings come from cells and rodents, with no human aging or longevity trials of apigenin to date. Second, apigenin's poor absorption (discussed below) raises real questions about whether ordinary oral doses reach the tissue concentrations that inhibit CD38 in a dish. The longevity case for apigenin is mechanistically elegant and worth watching, but it is not yet backed by human outcomes.

Anti-Cancer Cell Signaling (Preclinical)

Apigenin is one of the more heavily studied flavones in cancer biology, and the volume of laboratory work is genuinely large — but it is almost entirely preclinical. Apigenin is not a cancer treatment, and nothing here should be read as a reason to delay or replace medical care.

In cell-culture and animal studies, apigenin interferes with several of the signaling pathways that tumors depend on. It can trigger programmed cell death (apoptosis) and cause cells to pause their division cycle; it dampens pro-survival and pro-growth signals such as the PI3K/AKT, MAPK/ERK, JAK/STAT, NF-κB, and Wnt/β-catenin pathways; and it can blunt the migration and invasion that let cancer cells spread. Some studies report that it makes tumor cells more vulnerable to chemotherapy. These are mechanistically interesting and consistent across many cancer-cell types in the lab.

The gap is human evidence: there are no robust clinical trials showing that taking apigenin prevents or treats cancer in people, and the concentrations used in many dish experiments are higher than what diet or typical supplements achieve in the bloodstream. The reasonable interpretation is that apigenin is a worthwhile research target and that diets rich in flavone-containing vegetables are sensible — not that an apigenin pill is a cancer therapy.

Antioxidant and Anti-Inflammatory Mechanism

Like other flavonoids, apigenin is a direct antioxidant — its hydroxyl groups can neutralize reactive oxygen species — but its more important contribution is likely indirect. It influences the cell's own defense and inflammation machinery. Apigenin can help activate the Nrf2 pathway, which switches on the body's built-in antioxidant enzymes, and it tends to quiet NF-κB, a master switch that turns on inflammatory genes. The net effect in laboratory and animal models is lower production of inflammatory messengers such as TNF-α and various interleukins.

This anti-inflammatory action is a plausible common thread behind apigenin's other reported effects, since chronic low-grade inflammation is woven into cardiovascular aging, metabolic disease, and neurodegeneration. As with the rest of the apigenin story, most of this evidence is preclinical, and the practical takeaway is the familiar one: a diet rich in colorful, flavone-containing plants supports the body's antioxidant and anti-inflammatory systems.

Metabolic Effects

Several of apigenin's threads converge on metabolism. In the same animal work that established CD38 inhibition, apigenin-treated mice showed better glucose control and less fat buildup in the liver, with the rise in NAD+ and the resulting boost to sirtuin activity offered as the likely explanation. Other rodent and cell studies report improvements in insulin signaling, reduced markers of fatty liver, and favorable shifts in lipid handling, generally attributed to the combined NAD+/sirtuin and anti-inflammatory effects.

These findings dovetail with the broader nutrition literature, in which higher intake of flavonoid-rich foods tracks with lower rates of metabolic syndrome and type 2 diabetes. But those population studies reflect whole diets, not apigenin in isolation, and the mechanistic metabolic data remain preclinical. Apigenin is a reasonable part of a plant-forward eating pattern; it is not an established treatment for diabetes or fatty liver.

Forms, Dosing, and Bioavailability

The defining practical problem with apigenin is poor bioavailability. It is barely soluble in water (on the order of a couple of micrograms per milliliter), it is absorbed slowly and incompletely, and it is cleared fairly quickly — so a large fraction of an oral dose never reaches the bloodstream in active form. This is the central uncertainty hanging over every benefit claim: the concentrations that work in a dish may simply not be achievable from a normal capsule.

Common forms include:

Because evidence-based human dosing has not been established for isolated apigenin, no specific milligram target can be given with confidence. Taking it with a fat-containing meal is sensible (it is fat-soluble), and a cup of chamomile tea remains the lowest-risk way to experience the traditional calming effect.

Safety and Interactions

Apigenin and chamomile are generally regarded as safe, with a long history of dietary and herbal-tea use. Most people tolerate them well. The points below are sensible precautions, not alarms.

As always, if you take prescription medication or have a chronic condition, check with a healthcare professional before adding a concentrated supplement.

Back to Table of Contents

Research Papers

A selection of peer-reviewed papers on apigenin and chamomile across the calming/sleep, NAD+/CD38, anticancer, and metabolic domains. Each year/volume/pages citation links to the publisher record via its DOI. Note that the strongest human evidence is for chamomile extract rather than isolated apigenin, and that much apigenin data is preclinical.

  1. Escande C, Nin V, Price NL, et al. Flavonoid apigenin is an inhibitor of the NAD+ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes — 2013;62(4):1084–1093.
  2. Eskandari M, et al. Apigenin: a natural molecule at the intersection of sleep and aging. Frontiers in Nutrition — 2024;11:1359176.
  3. Amsterdam JD, Li Y, Soeller I, et al. A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. Journal of Clinical Psychopharmacology — 2009;29(4):378–382.
  4. Mao JJ, Xie SX, Keefe JR, et al. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: a randomized clinical trial. Phytomedicine — 2016;23(14):1735–1742.
  5. Hieu TH, Dibas M, Surya Dila KA, et al. Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: a systematic review and meta-analysis. Phytotherapy Research — 2019;33(6):1604–1615.
  6. Zick SM, Wright BD, Sen A, Arnedt JT. Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC Complementary and Alternative Medicine — 2011;11:78.
  7. Yan X, Qi M, Li P, et al. Apigenin in cancer therapy: anti-cancer effects and mechanisms of action. Cell & Bioscience — 2017;7:50.
  8. Salehi B, Venditti A, Sharifi-Rad M, et al. The therapeutic potential of apigenin. International Journal of Molecular Sciences — 2019;20(6):1305.
  9. Wang M, Firrman J, Liu L, Yam K. A review on flavonoid apigenin: dietary intake, ADME, antimicrobial effects, and interactions with human gut microbiota. BioMed Research International — 2019;2019:7010467.

Live PubMed Searches

  1. Apigenin and the GABA-A receptor
  2. Apigenin, CD38, and NAD+
  3. Chamomile and anxiety (randomized trials)
  4. Chamomile, sleep, and insomnia
  5. Apigenin, cancer, and apoptosis
  6. Apigenin and NF-κB inflammation
  7. Apigenin bioavailability and absorption
  8. Apigenin dietary sources and intake

Back to Table of Contents

Connections

Back to Table of Contents